Skip to Content

Etoposide Solution For Injection

Last Updated: June 15, 2018
Status: Current

Products Affected - Description
    • Toposar solution, Teva, 20 mg/mL, 25 mL multiple dose vial, 1 count, NDC 00703-5656-01
    • Toposar solution, Teva, 20 mg/mL, 5 mL multiple dose vial, 1 count, NDC 00703-5653-01
    • Toposar solution, Teva, 20 mg/mL, 50 mL multiple dose vial, 1 count, NDC 00703-5657-01
    • Etoposide solution, Accord, 20 mg/mL, 50 mL multiple dose vial, 1 count, NDC 16729-0114-11
    • Etoposide solution, Fresenius Kabi, 20 mg/mL, 25 mL multiple dose vial, 1 count, NDC 63323-0104-25
    • Etoposide solution, Fresenius Kabi, 20 mg/mL, 5 mL multiple dose vial, 10 count, NDC 63323-0104-05
    • Etoposide solution, West-Ward, 20 mg/mL, 25 mL multiple dose vial, 1 count, NDC 00143-9511-01
    • Etoposide solution, West-Ward, 20 mg/mL, 5 mL multiple dose vial, 1 count, NDC 00143-9510-01
    • Etoposide solution, West-Ward, 20 mg/mL, 50 mL multiple dose vial, 1 count, NDC 00143-9512-01
Reason for the Shortage
    • Accord has etoposide 20 mg/mL 5 mL and 25 mL vials on allocation and 50 mL vials on back order due to increased demand.
    • Fresenius Kabi has etoposide on back order due to increased demand.
    • Teva has Toposar on allocation due to increased demand.
    • West-Ward did not provide a reason for the shortage.
    • Etoposide phosphate powder for injection (Etopophos) is unaffected by this shortage.
Available Products
    • Etoposide solution, Accord, 20 mg/mL, 25 mL multiple dose vial, 1 count, NDC 16729-0114-08
    • Etoposide solution, Accord, 20 mg/mL, 5 mL multiple dose vial, 1 count, NDC 16729-0114-31
    • Etoposide solution, Fresenius Kabi, 20 mg/mL, 50 mL multiple dose vial, 1 count, NDC 63323-0104-50

Estimated Resupply Dates

    • Accord has etoposide 20 mg/mL 50 mL vials on back order and the company estimates a release date of July 2018.
    • Fresenius Kabi has etoposide 20 mg/mL 5 mL and 25 mL vials on back order and the company estimates a release date of mid-June 2018 for the 5 mL vials and late-June 2018 for the 25 mL vials. Check wholesalers for inventory.
    • Teva has Toposar 20 mg/mL 5 mL, 25 mL, and 50 mL vials on allocation.
    • West-Ward has etoposide 20 mg/mL 5 mL and 25 mL vials on back order and the company estimates release dates of early- to mid-July 2018. The 50 mL vials are on allocation.

Updated

Updated June 15, 2018 by Anthony Trovato, Pharmacy Resident. Created December 21, 2017 by Benjamin Witt, PharmD, BCPS, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide